Developing a new non-hormonal intravaginal ring for pregnancy and STI prevention
Official title: Investigating end-user perspectives to inform the development of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections
Funded at Population Council · NIH-10914852 · Data updated 2026-11-12
This study is looking for women of reproductive age to help test a new non-hormonal intravaginal ring that aims to prevent unwanted pregnancies and STIs, so your thoughts on how it feels and works will help make it better for everyone!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Population Council NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 22, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $864,345 |
| NIH project number | 5P50HD106793-04 |
| Project ID | NIH-10914852 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women aged 18-49 who are seeking non-hormonal contraceptive methods.
✕Less likely to help
Patients who are not of reproductive age or those who prefer hormonal contraceptive methods may not benefit from this research.
What this research studies
This research focuses on creating a non-hormonal intravaginal ring (IVR) designed to prevent unintended pregnancies and sexually transmitted infections (STIs). The study involves understanding the perspectives of women of reproductive age to ensure the product meets their needs and preferences. Researchers will evaluate various factors that influence the acceptability and intention to use this new IVR, including its physical characteristics and the benefits and risks associated with its active ingredients. Participants will engage in a crossover study where they will use different versions of the IVR to provide feedback on their experiences.
Why it matters
Potential benefit: If successful, this research could provide women with a safe and effective non-hormonal option for preventing pregnancy and STIs.
How similar studies have gone: Previous research has shown promise in developing user-centered contraceptive technologies, but this specific non-hormonal IVR approach is relatively novel.
Where this research is happening
-
Population Council
New York, United States Active
Researchers
- Principal investigator: Friedland, Barbara a — Population Council
- Study coordinator: Friedland, Barbara a
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.